Dos Santos G, Devadiga R, Kim CS, Bang J, et al. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged Drug Saf 2024 Mar 14. doi: 10.1007/s40264-024-01395.
PMID: 38483767